JP2023547346A5 - - Google Patents
Info
- Publication number
- JP2023547346A5 JP2023547346A5 JP2023522401A JP2023522401A JP2023547346A5 JP 2023547346 A5 JP2023547346 A5 JP 2023547346A5 JP 2023522401 A JP2023522401 A JP 2023522401A JP 2023522401 A JP2023522401 A JP 2023522401A JP 2023547346 A5 JP2023547346 A5 JP 2023547346A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dimethylamino
- ethoxy
- oxadiazole
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382888.4 | 2020-10-08 | ||
| EP20382888 | 2020-10-08 | ||
| PCT/EP2021/077660 WO2022074103A1 (en) | 2020-10-08 | 2021-10-07 | Potent and selctive compounds as serotonin 1b receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023547346A JP2023547346A (ja) | 2023-11-10 |
| JP2023547346A5 true JP2023547346A5 (https=) | 2024-07-23 |
| JP7687636B2 JP7687636B2 (ja) | 2025-06-03 |
Family
ID=73030029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023522401A Active JP7687636B2 (ja) | 2020-10-08 | 2021-10-07 | セロトニン１ｂ受容体モジュレーターとしての強力で選択的な新規化合物 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US12540133B2 (https=) |
| EP (2) | EP4445901A3 (https=) |
| JP (1) | JP7687636B2 (https=) |
| KR (1) | KR20230107566A (https=) |
| CN (1) | CN116635390B (https=) |
| AU (1) | AU2021356114A1 (https=) |
| CA (1) | CA3194700A1 (https=) |
| CL (1) | CL2023001021A1 (https=) |
| DK (1) | DK4225753T3 (https=) |
| ES (1) | ES2985416T3 (https=) |
| FI (1) | FI4225753T3 (https=) |
| HR (1) | HRP20241184T1 (https=) |
| HU (1) | HUE068199T2 (https=) |
| IL (1) | IL301806B1 (https=) |
| LT (1) | LT4225753T (https=) |
| MX (1) | MX2023004116A (https=) |
| PL (1) | PL4225753T3 (https=) |
| PT (1) | PT4225753T (https=) |
| RS (1) | RS65956B1 (https=) |
| SI (1) | SI4225753T1 (https=) |
| WO (1) | WO2022074103A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR123701A1 (es) | 2020-10-08 | 2023-01-04 | Merck Sharp & Dohme | Preparación de derivados de oxindol como nuevos inhibidores de la diacilglicerol o-aciltransferasa 2 |
| EP4382519A4 (en) * | 2021-08-27 | 2024-12-04 | Adlai Nortye Biopharma Co., Ltd. | CYCLIN K DEGRADING AGENT |
| AU2024302643A1 (en) | 2023-06-16 | 2026-01-22 | Leukos Biotech Sl | 5-htr1b modulator for use in the treatment of solid tumours |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW240217B (https=) * | 1992-12-30 | 1995-02-11 | Glaxo Group Ltd | |
| US5801170A (en) | 1993-12-07 | 1998-09-01 | Smithkline Beecham Plc | Heterocyclic biphenylylamides useful as 5HT1D antagonists |
| ZA985542B (en) * | 1997-07-03 | 1999-04-07 | Smithkline Beecham Corp | Substituted benzanilides as CCR5 receptor ligands antiinflammatory agents and antiviral agents |
| EP1098892A1 (en) | 1998-07-20 | 2001-05-16 | MERCK PATENT GmbH | Biphenyl derivatives |
| BR0112856A (pt) | 2000-07-31 | 2003-07-01 | Smithkline Beecham Plc | Método para o tratamento dos distúrbios, composto ou um sal ou solvato deste, processo para a preparação dos mesmos, composição farmacêutico, método de tratamento e/ou profilaxia de um ou mais dos distúrbios, uso de um composto, e, método para o tratamento de diabetes, grande depressão, depressão manìaca, ansiedade, esquizofrenia e distúrbios do sono, em mamìferos humanos e não humanos |
| US7105682B2 (en) | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
| WO2007057742A2 (en) | 2005-11-18 | 2007-05-24 | Pfizer Products Inc. | Novel piperazinone derivatives |
| WO2007077457A2 (en) * | 2006-01-06 | 2007-07-12 | The Royal Veterinary College | Treatment of equine laminitis with 5-ht1b/ 1d antagonists |
| EP3348266A1 (en) | 2017-01-16 | 2018-07-18 | Leukos Biotech, S.L. | Combination therapy for treating cancer |
-
2021
- 2021-10-07 FI FIEP21789678.6T patent/FI4225753T3/fi active
- 2021-10-07 DK DK21789678.6T patent/DK4225753T3/da active
- 2021-10-07 PL PL21789678.6T patent/PL4225753T3/pl unknown
- 2021-10-07 US US18/248,393 patent/US12540133B2/en active Active
- 2021-10-07 KR KR1020237015543A patent/KR20230107566A/ko active Pending
- 2021-10-07 HR HRP20241184TT patent/HRP20241184T1/hr unknown
- 2021-10-07 CN CN202180068969.0A patent/CN116635390B/zh active Active
- 2021-10-07 CA CA3194700A patent/CA3194700A1/en active Pending
- 2021-10-07 LT LTEPPCT/EP2021/077660T patent/LT4225753T/lt unknown
- 2021-10-07 IL IL301806A patent/IL301806B1/en unknown
- 2021-10-07 ES ES21789678T patent/ES2985416T3/es active Active
- 2021-10-07 PT PT217896786T patent/PT4225753T/pt unknown
- 2021-10-07 WO PCT/EP2021/077660 patent/WO2022074103A1/en not_active Ceased
- 2021-10-07 EP EP24191411.8A patent/EP4445901A3/en not_active Withdrawn
- 2021-10-07 RS RS20240938A patent/RS65956B1/sr unknown
- 2021-10-07 JP JP2023522401A patent/JP7687636B2/ja active Active
- 2021-10-07 AU AU2021356114A patent/AU2021356114A1/en active Pending
- 2021-10-07 SI SI202130183T patent/SI4225753T1/sl unknown
- 2021-10-07 MX MX2023004116A patent/MX2023004116A/es unknown
- 2021-10-07 HU HUE21789678A patent/HUE068199T2/hu unknown
- 2021-10-07 EP EP21789678.6A patent/EP4225753B1/en active Active
-
2023
- 2023-04-06 CL CL2023001021A patent/CL2023001021A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023547346A5 (https=) | ||
| JP2025023997A (ja) | Ｆａｋ阻害剤およびその併用薬物 | |
| JP2021523221A5 (https=) | ||
| US20120071513A1 (en) | Compositions and Their Use as Anti-Tumor Agents | |
| JP2021529812A5 (https=) | ||
| JP2020503299A5 (https=) | ||
| JP2009536620A5 (https=) | ||
| IL276575B2 (en) | Inhibitors of btk and mutants thereof | |
| JP2016513660A5 (https=) | ||
| KR20260042557A (ko) | 항암 및 항-증식 활성을 나타내는 2-아미노피리미딘-6-온 및 유사체 | |
| JP2019507179A5 (https=) | ||
| JP2020527173A5 (https=) | ||
| JP2011507854A5 (https=) | ||
| JP2016534134A5 (https=) | ||
| HRP20241184T1 (hr) | Moćni i selektivni spojevi kao modulatori serotonin 1b receptora | |
| JP2008517984A5 (https=) | ||
| JP2021502387A5 (https=) | ||
| US9101632B2 (en) | Kinase inhibitors, prodrug forms thereof and their use in therapy | |
| US20240051936A1 (en) | Isoindolinone compounds | |
| EA032639B1 (ru) | Гидрохлоридные соли n-(цианометил)-4-(2-(4-морфолинофениламино)пиримидин-4-ил)бензамида | |
| HRP20220472T1 (hr) | Novi derivati heteroarilamida kao selektivni inhibitori histonskih deacetilaza 1 i 2 (hdac1-2) | |
| JP2022017461A5 (https=) | ||
| CN105473573A (zh) | 用作激酶抑制剂的咔唑甲酰胺化合物 | |
| JP2022511477A5 (https=) | ||
| JP2017532357A5 (https=) |